ONCY News and Press, Oncolytics Biotech Inc. From 06/25/20

June 25, 2020 FN Media Group Presents USA News Group News Commentary Los Angeles, CA – June 25, 2020 – USA News Group  – In a major step forward, engineers from MIT have designed nanoparticles that stimulate the immune system, helping it to attack tumo...

June 25, 2020 Palm Beach, FL –June 25, 2020 – The triple negative breast cancer (TNBC) treatment market to grow at stellar CAGR through 2026. A recent report from Cole Market Research has stated that the ongoing advancements in cancer research continue to lead to the...

Oncolytics Biotech (NASDAQ: ONCY ) announces a new investigator-sponsored triple-negative breast cancer (TNBC) study to be managed by Rutgers Cancer Institute of New Jersey. More news on: Oncolytics Biotech Inc., Incyte Corporation, Healthcare stocks news, Read more ...

SAN DIEGO and CALGARY, Alberta , June 25, 2020 /PRNewswire/ -- Oncolytics Biotech ®  Inc. (NASDAQ: ONCY) (TSX: ONC), today announced a new investigator-sponsored triple-negative breast cancer (TNBC) study to be managed by Rutgers Cancer Institute of New Jersey . The phase 2 ...

Oncolytics Biotech (NASDAQ: ONCY ) doses first patient in its phase 2 study of pelareorep-based combination therapies in HR+/HER2- metastatic breast cancer (mBC). More news on: Oncolytics Biotech Inc., Merck & Co., Inc., Pfizer Inc., Healthcare stocks news, Stocks on the move, Re...

June 23, 2020 Palm Beach, FL –June 23, 2020 – Metastatic breast cancer (also called stage IV) is breast cancer that has spread to another part of the body, most commonly the liver, brain, bones, or lungs. Metastatic disease is NOT hopeless. Many people continue to li...

Fuwei Films (NASDAQ: FFHL ) +66%  on Q1 results . More news on: Fuwei Films (Holdings) Co., Ltd., Translate Bio, Inc., Recon Technology, Ltd., Stocks on the move, , Read more ...

SAN DIEGO and CALGARY, Alberta , June 23, 2020 /PRNewswire/ -- Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), today announced the first patient has been dosed in the Company's phase 2 study of pelareorep-based combination therapies in HR+/HER2- metastatic breast cancer (mBC). ...

Oncolytics Biotech® Establishes New At-The-Market Facility Canada NewsWire SAN DIEGO, Calif. and CALGARY, Alberta, June 15, 2020 SAN DIEGO, Calif. and CALGARY, Alberta , June 15, 2020 /CNW/ -- Oncolytics Biotech ®  Inc. (NASDAQ: ONCY) (TSX: ONC), cur...

June 4, 2020 Recently announced clinical data demonstrate pelareorep-induced priming of an adaptive immune response Pro-inflammatory effects of pelareorep observed across multiple breast cancer subtypes Data support further clinical development of pelareorep-anti-PD-L1 ...